Results 191 to 200 of about 3,084 (231)
Some of the next articles are maybe not open access.
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2021
The evidence is mounting for a role for abnormal signaling of the stress peptide pituitary adenylate cyclase activating polypeptide (PACAP) and its canonical receptor PAC1 in the pathogenesis of sudden infant death syndrome. In this study, we investigated whether the PACAP receptors PAC1 or VPAC2 are involved in the neonatal cardiorespiratory response
Karlene T. Barrett +3 more
openaire +2 more sources
The evidence is mounting for a role for abnormal signaling of the stress peptide pituitary adenylate cyclase activating polypeptide (PACAP) and its canonical receptor PAC1 in the pathogenesis of sudden infant death syndrome. In this study, we investigated whether the PACAP receptors PAC1 or VPAC2 are involved in the neonatal cardiorespiratory response
Karlene T. Barrett +3 more
openaire +2 more sources
Role of VPAC2 receptor in monocrotaline-induced pulmonary hypertension in rats
Journal of Applied Physiology, 2014Pulmonary hypertension (PH) is associated with significant morbidity and mortality. Vasoactive intestinal peptide (VIP) and pituitary adenylyl cyclase activating peptide (PACAP) have pulmonary vasodilatory and positive inotropic effects via receptors VPAC1 and VPAC2, which possess a similar affinity for both peptides, and PAC1, a PACAP-preferring ...
Motokazu, Koga +4 more
openaire +2 more sources
Hexanoylation of a VPAC2 receptor-preferring ligand markedly increased its selectivity and potency
Peptides, 2004We synthesized a VIP analog that combines mutations that decrease the affinity for the VPAC1 receptor but maintain a high affinity for the VPAC2 receptor with an amino-terminal hexanoylation that increases the affinity for the VPAC2 receptor with a limited decrease in the affinity of the VPAC1 receptor.
Langer, Ingrid +5 more
openaire +2 more sources
Molecular Brain Research, 2002
PACAP and VIP are members of the VIP/secretin/glucagon family of peptides with neurotransmitter, neuroprotective, and neurotrophic functions. PACAP and VIP are known to be upregulated in primary sensory neurons following nerve injury, implying that these neuropeptides could be mediators of sensory transmission in neuropathic pain states.
Priya, Chaudhary, Thomas K, Baumann
openaire +2 more sources
PACAP and VIP are members of the VIP/secretin/glucagon family of peptides with neurotransmitter, neuroprotective, and neurotrophic functions. PACAP and VIP are known to be upregulated in primary sensory neurons following nerve injury, implying that these neuropeptides could be mediators of sensory transmission in neuropathic pain states.
Priya, Chaudhary, Thomas K, Baumann
openaire +2 more sources
VPAC2 receptor mediates VIP-potentiated insulin secretion via ion channels in rat pancreatic β cells
Experimental Cell Research, 2023Vasoactive intestinal peptide (VIP), a small neuropeptide composing of 28 amino acids, functions as a neuromodulator with insulinotropic effect on pancreatic β cells, in which it is of vital importance in regulating the levels of blood glucose. VIP potently agonizes VPAC2 receptor (VPAC2-R).
Xin Zhao +9 more
openaire +2 more sources
Combinatorial Chemistry & High Throughput Screening, 2015
Vasoactive intestinal polypeptide (VIP) is an intrinsic 28-amino acid peptide, involved in a wide range of physiologic effects, and therefore considered as a promising drug candidate for the treatment of several diseases. But the clinical application of VIP has been limited for the easy in vivo digestion.
Jiazhong, Li +3 more
openaire +2 more sources
Vasoactive intestinal polypeptide (VIP) is an intrinsic 28-amino acid peptide, involved in a wide range of physiologic effects, and therefore considered as a promising drug candidate for the treatment of several diseases. But the clinical application of VIP has been limited for the easy in vivo digestion.
Jiazhong, Li +3 more
openaire +2 more sources
Development of Selective Ligands for Pac1, Vpac1 and Vpac2 Receptors
2003At the time of its isolation, purification and sequencing in 1970-1972 by Said and Mutt (Said and Mutt, 1972;Mutt and Said, 1974), VIP was the third identified member of a peptide group that included secretin (Mutt et al, 1970) and glucagon (Bromer et al, 1957).
P. Robberecht +3 more
openaire +1 more source
The Journal of Pharmacology and Experimental Therapeutics, 2005
Prepro-vasoactive intestinal peptide (VIP) mRNA codes for two neuropeptides: VIP and peptide histidine isoleucine (PHI). Two VIP receptors, shared with a similar affinity by pituitary adenylate cyclase-activating polypeptide (PACAP), have been cloned: VPAC(1) and VPAC(2). PHI binds to these receptors with a lower affinity.
Rangon, Claire-Marie +9 more
openaire +3 more sources
Prepro-vasoactive intestinal peptide (VIP) mRNA codes for two neuropeptides: VIP and peptide histidine isoleucine (PHI). Two VIP receptors, shared with a similar affinity by pituitary adenylate cyclase-activating polypeptide (PACAP), have been cloned: VPAC(1) and VPAC(2). PHI binds to these receptors with a lower affinity.
Rangon, Claire-Marie +9 more
openaire +3 more sources

